Cadrenal Therapeutics
CVKD
#9801
Rank
C$43.2 M
Marketcap
$22.99
Share price
-5.66%
Change (1 day)
86.09%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -$9.43

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -$9.87. In 2023 the company made an earnings per share (EPS) of -$13.21.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$9.43-28.6%
2023-$13.21